STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD

Deep Remission at 1 Year Prevents Progression of Early Crohn’s Disease

(2020) Ryan C. Ungaro et al.   GASTROENTEROLOGY

Predictors of Long-Term Clinical and Endoscopic Remission in Children With Crohnʼs Disease Treated With Infliximab

(2019) Giulia D’Arcangelo et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Consecutive fecal calprotectin measurements for predicting relapse in pediatric Crohn’s disease patients

(2019) Alice Jane Foster et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Development and Validation of the Mucosal Inflammation Noninvasive Index For Pediatric Crohn’s Disease

(2019) Martinus A. Cozijnsen et al.   Clinical Gastroenterology and Hepatology

Combined evaluation of biomarkers as predictor of maintained remission in Crohn’s disease

(2019) Elisa Sollelis et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Time-to-reach target calprotectin level in newly diagnosed patients with Inflammatory bowel disease

(2019) Sjoukje-Marije Haisma et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Multiparametric Evaluation Predicts Different Mid-Term Outcomes in Crohn’s Disease

(2018) Lucrezia Laterza et al.   DIGESTIVE DISEASES

Biomarker-Based Models Outperform Patient-Reported Scores in Predicting Endoscopic Inflammatory Disease Activity

(2018) Marc W Morris et al.   INFLAMMATORY BOWEL DISEASES

The Association Between Sustained Poor Quality of Life and Future Opioid Use in Inflammatory Bowel Disease

(2018) Alyce Anderson et al.   INFLAMMATORY BOWEL DISEASES

OP015 Biomarker correlation with endoscopic outcomes in patients with Crohn’s disease: data from CALM

(2018) W Reinisch et al.   Journal of Crohns & Colitis

Effect of Laparoscopic Surgery on Quality of Life in Ulcerative Colitis

(2018) János Tajti et al.   Journal of Laparoendoscopic & Advanced Surgical Techniques

Accuracy of Humanitas Ultrasound Criteria in Assessing Disease Activity and Severity in Ulcerative Colitis: A Prospective Study

(2018) Mariangela Allocca et al.   Journal of Crohns & Colitis

Fecal calprotectin in assessing inflammatory bowel disease endoscopic activity: a diagnostic accuracy meta-analysis

(2018)   Journal of Gastrointestinal and Liver Diseases

Clinical Parameters Correlate With Endoscopic Activity of Ulcerative Colitis—a Systematic Review

(2018) Sophie Restellini et al.   Clinical Gastroenterology and Hepatology

The combination of fecal calprotectin with ESR, CRP and albumin discriminates more accurately children with Crohn’s disease

(2018) Urszula Daniluk et al.   Advances in Medical Sciences

Noninvasive Fecal Immunochemical Testing and Fecal Calprotectin Predict Mucosal Healing in Inflammatory Bowel Disease

(2017) Christopher Ma et al.   INFLAMMATORY BOWEL DISEASES

Clinical Utility of Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease

(2017) Anke Heida et al.   INFLAMMATORY BOWEL DISEASES

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

(2017) Jean-Frederic Colombel et al.   LANCET

Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease

(2017) Athanasios Kostas et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China

(2017) Jin-Min Chen et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Disability in Patients with Inflammatory Bowel Disease: Correlations with Quality of Life and Patient’s Characteristics

(2017) Konstantinos Argyriou et al.   Canadian Journal of Gastroenterology and Hepatology

Relapse after withdrawal from anti-TNF therapy for inflammatory bowel disease: an observational study, plus systematic review and meta-analysis

(2016) N. A. Kennedy et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study

(2016) A. Stallmach et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Discrepancies between patient-reported outcomes, and endoscopic and histological appearance in UC

(2016) Jean-Frédéric Colombel et al.   GUT

Fecal Calprotectin Predicts Relapse and Histological Mucosal Healing in Ulcerative Colitis

(2016) Klaus Theede et al.   INFLAMMATORY BOWEL DISEASES

Accuracy of Consecutive Fecal Calprotectin Measurements to Predict Relapse in Inflammatory Bowel Disease Patients Under Maintenance With Anti-TNF Therapy

(2016) Rocio Ferreiro-Iglesias et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Quality of Life Is Related to Fecal Calprotectin Concentrations in Colonic Crohn Disease and Ulcerative Colitis, but not in Ileal Crohn Disease

(2016) Annika Gauss et al.   MEDICINE

Determination of faecal inflammatory marker concentration as a noninvasive method of evaluation of pathological activity in children with inflammatory bowel diseases

(2015) Dorota Roszak et al.   Advances in Medical Sciences

Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti-TNF therapy

(2015) J. P. Gisbert et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

(2015) L Peyrin-Biroulet et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis

(2015) Maria Theresa Arias et al.   Clinical Gastroenterology and Hepatology

Clinical, biological, and endoscopic responses to adalimumab in antitumor necrosis factor-naive Crohn’s disease

(2015) Ana Echarri et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Biomarkers of Inflammation in Inflammatory Bowel Disease

(2015) Bruce E. Sands   GASTROENTEROLOGY

Accuracies of Serum and Fecal S100 Proteins (Calprotectin and Calgranulin C) to Predict the Response to TNF Antagonists in Patients with Crohnʼs Disease

(2015) Gilles Boschetti et al.   INFLAMMATORY BOWEL DISEASES

Combination of C-reactive Protein, Infliximab Trough Levels, and Stable but Not Transient Antibodies to Infliximab Are Associated With Loss of Response to Infliximab in Inflammatory Bowel Disease

(2015) X. Roblin et al.   Journal of Crohns & Colitis

Predictive value of early restoration of quality of life in Crohn's disease patients receiving antitumor necrosis factor agents

(2015) Claudia Herrera-deGuise et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation

(2015) Martin Bortlik et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity

(2014) R. Khanna et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Fatigue is highly associated with poor health-related quality of life, disability and depression in newly-diagnosed patients with inflammatory bowel disease, independent of disease activity

(2014) B. L. Cohen et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year

(2014) Luisa Guidi et al.   DIGESTIVE AND LIVER DISEASE

Effectiveness and safety of infliximab and adalimumab for ambulatory Crohn's disease patients in primary gastroenterology centres

(2014) Antonio Tursi et al.   European Journal of Internal Medicine

Postinduction serum infliximab trough level and decrease of C-reactive protein level are associated with durable sustained response to infliximab: a retrospective analysis of the ACCENT I trial

(2014) Freddy Cornillie et al.   GUT

Comparison of Outcomes Parameters for Induction of Remission in New Onset Pediatric Crohnʼs Disease

(2014) Arie Levine et al.   INFLAMMATORY BOWEL DISEASES

Assessment of Histologic Disease Activity in Crohnʼs Disease

(2014) Amirkaveh Mojtahed et al.   INFLAMMATORY BOWEL DISEASES

Slight Increases in the Disease Activity Index and Platelet Count Imply the Presence of Active Intestinal Lesions in C-reactive Protein-negative Crohn's Disease Patients

(2014) Asuka Nakarai et al.   INTERNAL MEDICINE

Rapid Fecal Calprotectin Level Assessment and the SIBDQ Score can Accurately Detect Active Mucosal Inflammation in IBD Patients in Clinical Remission: a Prospective Study

(2014)   Journal of Gastrointestinal and Liver Diseases

Sexual Function and Body Image are Similar after Laparoscopy-Assisted and Open Ileal Pouch–Anal Anastomosis

(2014) Mie Dilling Kjaer et al.   WORLD JOURNAL OF SURGERY

Endoscopic and Clinical Variables That Predict Sustained Remission in Children With Ulcerative Colitis Treated With Infliximab

(2013) Dan Turner et al.   Clinical Gastroenterology and Hepatology

Adalimumab Induces Deep Remission in Patients With Crohn's Disease

(2013) Jean–Frédéric Colombel et al.   Clinical Gastroenterology and Hepatology

Evaluation of the Patient-Reported Outcomes Measurement Information System in a Large Cohort of Patients With Inflammatory Bowel Diseases

(2013) Michael D. Kappelman et al.   Clinical Gastroenterology and Hepatology

Histologic Remission: The Ultimate Therapeutic Goal in Ulcerative Colitis?

(2013) Laurent Peyrin–Biroulet et al.   Clinical Gastroenterology and Hepatology

Correlations of C-reactive Protein Levels and Erythrocyte Sedimentation Rates with Endoscopic Activity Indices in Patients with Ulcerative Colitis

(2013) Jin Young Yoon et al.   DIGESTIVE DISEASES AND SCIENCES

Correlation Between the Endoscopic and Histologic Score in Assessing the Activity of Ulcerative Colitis

(2013) Bart Lemmens et al.   INFLAMMATORY BOWEL DISEASES

Fecal calprotectin and lactoferrin as predictors of relapse in patients with quiescent ulcerative colitis during maintenance therapy

(2013) Takayuki Yamamoto et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Serum calprotectin as a biomarker for Crohn's disease

(2013) M.-A. Meuwis et al.   Journal of Crohns & Colitis

Sexual activity after ileal pouch-anal anastomosis in Japanese patients with ulcerative colitis

(2013) Kazue Yoshida et al.   SURGERY TODAY

Quality of Life in the First 6 Weeks Following Laparoscopic and Open Colorectal Surgery

(2013) Henry M. Dowson et al.   VALUE IN HEALTH

Mucosal healing in inflammatory bowel diseases: a systematic review

(2012) Markus F Neurath et al.   GUT

Usefulness of Faecal Calprotectin Measurement in Children with Various Types of Inflammatory Bowel Disease

(2012) Marzena Komraus et al.   MEDIATORS OF INFLAMMATION

Intestinal Inflammation and Cancer

(2011) Thomas A. Ullman et al.   GASTROENTEROLOGY

How Rapidly Should Remission Be Achieved?

(2010) Kim L. Isaacs   DIGESTIVE DISEASES

Mucosal healing as an index of colitis activity: Back to histological healing for future indices

(2010) Burton I. Korelitz   INFLAMMATORY BOWEL DISEASES

Faecal calprotectin in children with clinically quiescent inflammatory bowel disease

(2010) Taina Sipponen et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

A Systematic Prospective Comparison of Noninvasive Disease Activity Indices in Ulcerative Colitis

(2009) Dan Turner et al.   Clinical Gastroenterology and Hepatology

Ulcerative colitis

(2009) Alain M. Schoepfer et al.   INFLAMMATORY BOWEL DISEASES

Appraisal of the pediatric ulcerative colitis activity index (PUCAI)

(2009) Dan Turner et al.   INFLAMMATORY BOWEL DISEASES

Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease

(2008) R. Berni Canani et al.   DIGESTIVE AND LIVER DISEASE

Fecal calprotectin levels and serological responses to microbial antigens among children and adolescents with inflammatory bowel disease

(2008) Sara Ashorn et al.   INFLAMMATORY BOWEL DISEASES